RACEMIC-ISOMER
Compound with spectra: 2 NMR
| SpectraBase Compound ID | EGoevtm9Jgh |
|---|---|
| InChI | InChI=1S/C16H34Cl4N10O4P6/c17-35(18)23-37(27-39(25-35)31-13-5-14-32-39)21-7-3-11-29(37)9-1-2-10-30-12-4-8-22-38(30)24-36(19,20)26-40(28-38)33-15-6-16-34-40/h21-22H,1-16H2 |
| InChIKey | BWMQUTPDERNBAY-UHFFFAOYSA-N |
| Mol Weight | 758.2 g/mol |
| Molecular Formula | C16H34Cl4N10O4P6 |
| Exact Mass | 755.994432 g/mol |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
- MESO-ISOMER
NCEJXIQYVKPIKC-UHFFFAOYSA-N
SPIRO[4,4-DICHLORO-6,6-DIPHENYLCYCLOTRIPHOSPHAZENE-2,2'-(1',3'-DIMETHYL-1',3',2'-DIAZAPHOSPHOLANE)]
2,4-DIETHOXY-2-(BETA-NAPHTHOXY)-4,6,6-TRICHLOROCYCLOTRIPHOSPHAZATRIENE
LEPTOCLINIDAMINE_B
1-(1,3-benzodioxol-5-ylmethyl)-4-({1-[(3,5-dimethyl-4-isoxazolyl)sulfonyl]-4-piperidinyl}carbonyl)piperazine
(1S,2S,3S,5R)-2-[(E)-3(S)-HYDROXY-1-OCTENYL]-3-(METHOXYCARBONYLMETHYL)-6,8-DIOXABICYCLO[3.2.1]OCTAN-4-ONE
(1S,2S,3S,5R)-2-[(E)-3(R)-HYDROXY-1-OCTENYL]-3-(METHOXYCARBONYLMETHYL)-6,8-DIOXABICYCLO[3.2.1]OCTAN-4-ONE
3-Butyl-4-(4-methoxyphenyl)-5-phenylfuran-2(5H)-one
1,2,4-Oxadiazol-5-amine, N-(1,3-benzodioxol-5-ylmethyl)-3-[4-[(4-methoxyphenyl)amino]-1,2,5-oxadiazol-3-yl]-
4-thiazolidinone, 3-(4-morpholinyl)-5-(6-quinoxalinylmethylene)-2-thioxo-, (5E)-
| Title | Journal or Book | Year |
|---|---|---|
| Anomalous NMR Behavior of Meso Compounds with Remote Stereogenic Centers on Addition of Chiral Shift Reagent or Chiral Solvating Agent | Journal of the American Chemical Society | 2003 |
This compound is available in the following databases:
KnowItAll NMR Spectral Library
Author: Wiley
The KnowItAll NMR Spectral Library offers a comprehensive collection of NMR reference spectra, including NMR, CNMR, and XNMR, and covers a wide range of compounds including organics, polymers, monomers, metabolites, and more. Learn more.